GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nascent Biotech NBIO · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Nascent Biotech — daily NBIO Delayed
Market value
$34,444
Last close × shares
Volume
10k
Shares, 30 Oct 2026

About Nascent Biotech

Its shares trade under the ticker NBIO. It has been listed since 6 June 2012. In the fiscal year to 31 March 2022, it reported revenue of $1.0m and a net loss of $470,390. At that date it held total assets of $105,414 and shareholders' equity of −$671,476.

Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of monoclonal antibodies for the treatment of various forms of cancer. The company is headquartered in North Palm Beach, Florida. The company went IPO on 2012-06-06. The firm focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The company owns a drug candidate, Pritumumab, which the Company is developing as a treatment for epithelial cancers that includes lung, breast, colon, brain, and pancreas. Its initial focus is on patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma. The firm is exploring Pritumumab in its use against viruses. The firm is also engaged in developing a traditional vaccine platform to create vaccines for viral infections.

Figures and description from our data supplier, not checked against the company's own report.

More about Nascent Biotech →

Latest on Nascent Biotech

Our reporting

We have not reported on Nascent Biotech yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Nascent Biotech's ticker?

Nascent Biotech trades as NBIO on its US listing, under ISIN US63108Q1013.

What was Nascent Biotech's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.